Abstract
Gastroduodenal mucosal damage was endoscopically compared between aceclofenac, a non-steroidal anti-inflammatory drug, and sodium diclofenac or placebo in a double-blind clinical trial. Thirty healthy male volunteers received 150 mg/ day of aceclofenac, 75 mg/day of sodium diclofenac or placebo for 2 weeks. Aceclofenac caused significantly less gastropathy than sodium diclofenac, and placebo caused no gastropathy. Both the gastric mucosal hexosamine content and gastroduodenal blood flow were significantly reduced by sodium diclofenac, while gastric mucosal hexosamine was significantly increased and gastroduodenal blood flow was unchanged with aceclofenac. Aceclofenac appears to have a low potential for causing gastroduodenal mucosal damage in humans.
Similar content being viewed by others
References
Fries JF, NSAID gastropathy: epidemiology,J Musculoskel Med 8, 21–28 (1991).
Ballesteros R, Ansoleaga JJ, Tapounet R, The efficacy and tolerance of aceclofenac in rheumatoid arthritis. A double-blind study vs. placebo,Clin Trials J 27, 12–19 (1990).
Giorgianni G, Ottaviani C, Soliano Aet al., Efficacy and tolerability of aceclofenac versus ketoprofen in the treatment of rheumatoid arthritis,Curr Ther. Res 51, 175–184 (1992).
Torri G, Vignati C, Agrifoglio E,et al., Aceclofenac versus piroxicam in the management of osteoarthritis of the knee,Curr Ther Res 55, 576–583 (1994).
Birrell DH, Roma J, Bowdler JM, Evaluation of the efficacy and safety of aceclofenac in the treatment of osteoarthritis,Br J Clin Res 6, 45–55 (1995).
Mizushima Y, Phase II study of aceclofenac in patients with rheumatoid arthritis, Technical Report, Yakult Honsha Co., Ltd., Japan (1994).
Aoki T, Phase II study of aceclofenac in patients with osteoarthritis of the knee, Technical Report, Teikoku Hormone Manufacturing Co., Ltd., Japan (1994).
Lanza FL, Royer GL, Nelson RS,et al., The effects of ibuprofen, indomethacin, aspirin, naproxen, and placebo on the gastric mucosa of normal volunteers,Dig Dis Sci 24, 823–828 (1979).
Lanza FL, Royer GL, Nelson RS,et al., A comparative endoscopic evaluation of the damaging effects of nonsteroidal anti-inflammatory agents on the gastric and duodenal mucosa,Am J Gastroenterol 75, 17–21 (1981).
McCarthy DM, Nonsteroidal anti-inflammatory drug-induced ulcers. Management by traditional therapies,Gastroenterology 96, 662–674 (1989).
Yanagawa A, Endo T, Nakagawa T,et al., Prophylactic efficacy of ranitidine against gastroduodenal mucosal damages from nonsteroidal anti-inflammatory drugs. A randomized placebocontrolled study,R Soc Med 21, 97–103 (1990).
Yanagawa A, Nakagawa T, Mizushima Y, Gastropathy due to nonsteroidal anti-inflammatory drugs and preventive effects of teprenone and H2-blockers,Jpn J Clin Exp Med 67, 941–946 (1990).
Yanagawa A, Fukumura T, Matsui H,et al., Possible mechanisms of gastroduodenal mucosal damage in volunteers treated with nonsteroidal antiinflammatory drugs. The usefulness of prodrug,J Rheumatol 19, 1075–1082 (1992).
Saita H, Study of the measurement of gastric mucosal blood flow in rats using the laser doppler method,Gastroenterologia Japonica 81, 16–21 (1984).
Saita H, Reevaluation of gastric mucosal blood flow by the laser Doppler method,Gastroenterologia Japonica 86, 1235–1240 (1989).
Oketani K, Simple colorimetric assay method of mucoglycoprotein as an index of hexosamine,J Clin Exp Med 131, 745–749 (1984).
Azumi Y, Ohara S, Ishihara K, Correlation of quantitative changes of gastric mucosal glycoproteins with aspirin-induced gastric damage in rats,Gut 21 533–601 (1980).
Neuhaus OW, Letzring M, Determination of hexosamines in conjugation with electrophoresis on starch,Anal Chem 29, 1230–1233 (1957).
Grau M, Guasch J, Montero JL,et al., Pharmacology of the potent new non-steroidal antiinflammatory agent aceclofenac,Arzneim-Forsch 41, 1265–1276 (1991).
Pasero G, Ruju G, Marcolongo R,et al., Aceclofenac versus naproxen in the treatment of ankylosing spondylitis. A double-blind, controlled study,Curr Ther Res 55, 833–842 (1994).
Agrifoglio E, Benventi M, Gatto P,et al., Aceclofenacn: A new NSAID in the treatment of acute lumbago. Multicentre single blind study vs. diclofenanc,Acta Therapeutica 20, 33–45 (1994).
Sainz Olall F, Analgesic efficacy of aceclofenac. Double-blind controlled study vs. placebo in odontalgia,Curr Ther Res 43, 900–902 (1988).
Movilia PG, Evaluation of the analgesic activity and tolerability of aceclofenac in the treatment of post-episiotomy pain,Drugs Exp Clin Res 15, 47–51 (1989).
Puigvert Torrent A, Dose—response study of the analgesic activity of oceclogenac in odontalgia following extraction of the third molar,Drug Invest 2, 132–136 (1990).
Asaki S, Asaka M, Fujino M,et al., Endoscopic examination of gastric ulcers in rheumatoid arthritis patients during NSAIDs administration in Japan,Endoscopia Digestiva 5, 497–504 (1993).
Rimbau V, Fernandez MF, Guirao I,et al., Comparative study of the gastrointestinal tolerance of diclofenac and aceclofenac,ll Farmaco Ed Paractica 43, 19–26 (1988).
Wassif W, Bjarnason I, A comparison of the effects of aceclofenac and diclofenac on gastrointestinal blood loss,Br J Clin Res 3, 109–114 (1992).
Robert A, Prostaglandins and gastrointestinal tract, in:Physiology of the Gastrointestinal Tract, pp. 1407–1434, Raven Press, New York (1981).
Ligumisky M, Endogenous gastric prostaglandins, their role in mucosal integrity,Am J Physiol 242, G429-G432 (1982).
Takeuchi T, Mechanism of onset of indomethacin-induced gastropathy,Clin Rep 8, 167–177 (1989).
Peris F, Bird HA, Serni U,et al., Treatment compliance and safety of acecelofenac versus standard NSAIDs in patients with common arthritic disorders: a meta-analysis,Eur J Rheum Inflam 16, 37–45 (1996).
Yamazaki R, Matsuzaki T, Kaneda N,et al., Anti-inflammatory effect of aceclofenac on inflammation cells,Rheumatol in Eur 24 (suppl. 3), 273 (1995).
Dingle JT, The effect of NSAIDs on human articular cartilage glycosaminoglycan synthesis,Eur J Rheum Inflam 16, 47–52 (1996).
Author information
Authors and Affiliations
About this article
Cite this article
Yanagawa, A., Endo, T., Kusakari, K. et al. Endoscopic evaluation of aceclofenac-induced gastroduodenal mucosal damage: a double-blind comparison with sodium diclofenac and placebo. Japanese Journal of Rheumatology 8, 249–259 (1998). https://doi.org/10.1007/BF03041246
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF03041246